Sarcoma and mesenchymal tumors Flashcards
Molecular features of sarcomas as a class
30% translocation-associated
70% complex karyotype
Translocations in alveolar rhabdomyosarcoma
PAX3-FOXO1A - 75%
PAX7-FOXO1A - 20%
PAX3 with various partners (FOXO4, NCOA1, NCOA2, AFX) - 5%
Translocations in alveolar soft part sarcoma
ASPSCR1-TFE3 - >95% of cases
Translocations in angiomatoid fibrous histiocytoma
EWSR1-CREB1 72%
EWSR1-ATF1 21%
FUS-AFT1 7%
EWSR1-CREM Rare
Molecular features in angiosarcoma, radiation associated
MYC amplification
Molecular features in atypical lipomatous tumor / well differentiated liposarcoma
HMGIC, CDK4, and MDM2 amplification
Translocations in biphenotypic sinonasal sarcoma
PAX3-MAML3 (most common)
PAX3-FOXO1
PAX3-NCOA1
PAX3-NCOA2
PAX3-WWTR1
Translocations in clear cell sarcoma of soft parts
EWSR1-ATF1 - 90%
EWSR1-CREB1 - 10%
EWSR1-CREM - Rare
Molecular features in clear cell sarcoma of the kidney
BCOR internal tandem duplications
Some overlap with renal sarcomas harboring BCOR-CCNB3 or YWAAE-NUTM2B
Translocations in dermatofibrosarcoma protuberans
COL1A1-PDGFB - 95% of cases
Rarely other PDGFB partners
Translocations in desmoplastic small round cell tumor
EWSR1-WT1 - >95% of cases
Translocations in low grade endometrial stromal sarcoma
JAZF1-SUZ12
JAZF1-PHF1
JAZF1-BCORL1
EPC1-PHF1
MEAF6-PHF1
BRD8-PHF1
MBTD1-CXorf67
Translocations in high grade endometrial stromal sarcoma
KDM2B-BREBBP
YWHAE-NUTM2B
ZC3H7B-BCOR
Translocations in epithelioid hemandioendothelioma
WWTR1-CAMTA1 - 85% of cases
TFE3-YAP1
Translocations in Ewing sarcoma and PNET/Ewing family of tumors
EWSR1-FLI1 (90%)
EWSR1-ERG (5%)
other EWSR1 partners: ETV1, ETV4, FEV, PATZ1, SP3, NFATC2, SMARCA5, POU5F1
FUS-ERG
FUS-FEV
Translocations in extraskeletal myxoid chondrosarcoma
EWSR1-NR4A3 (75%)
TAF15-NR4A3 (15%)
TCF12-NR4A3
TFG-NR4A3
HSPA8-NR4A3
NR4A3-FUS
Translocations in infantile fibrosarcoma
ETV6-NTRK3 (>95%)
EML4-NTRK3
BRAF fusions
Translocations in uterine epithelioid leioyosarcoma
NRA4A3-PGR and other PGR rearrangements
Translocations in uterine myxoid leiomyosarcomas
TRPS1-PLAG1
RAD51B-PLAG1
Translocations in low-grade fibromyxoid sarcoma
FUS-CRE3L2 (>95%)
FUS-CREB3L1 (less than 5%)
EWSR1-CREB3L1
Translocations in malignant tenosynovial giant cell tumor
CSF1-COL6A3
Translocations in mesenchymal chondrosarcoma
HEY1-NCOA2 (>90%)
Translocations in myoepithelial tumors of soft tissue
EWSR1-POU5F1
EWSR1-ZNF444
EWSR1-PBX1
EWSR1-PBX3
EWSR1-KLF17
EWSR1-ATF1
Translocations in myxoid liposarcoma
FUS-DDIT3 (90%)
EWSR1-DDIT3 (10%)
Translocations in myxoinflammatory fibroblastic sarcoma
TGFBR3-MGEA5
Translocations in ossifying fibromyxoid tumor
MEAF6-PHF1
EPC1-PHF1
EP400-PHF1
PHF1-TFE3
ZC3H7B-BCOR
CREBBP-BCORL1
KDM2A-WWTR1
Translocations in perivascular epithelioid cell tumor (PEComa)
TSC2 mutation (unless TFE3 rearranged)
PSF-TFE3
DVL2-TFE3
NONO-TFE3
RBMX-TFE3
RAD51B-RRAGB
HTR4-ST3GALI
RASSF1-PDZRN3
SCL4A10-ROS1
ROS1-NETO1
Translocations in PRDM10-rearranged soft tissue tumor
CITED2-PRDM10
MED12-PRDM10
Translocations in pseudomyogenic hemangioendothelioma
SERPINE1-FOSB (50%)
ACTB-FOSB (50%)
Translocations in primary pulmonary myxoid sarcoma
EWSR1-CREB1
Translocations in sclerosing epithelioid fibrosarcoma
EWSR1-CREB2L2
EWSR1-CREB2L1
RESR1-CREB3L3
FUS-CREB3L2
Translocations in solitary fibrous tumor
NAB2-STAT6 (>95%)
Translocations in spindle cell / sclerosing rhabdomyosarcoma
VGLL2-CITED2
NCOA2 fusions
or
MYOD1 L122R
Translocations in synovial sarcoma
SS18-SSX1 (65%)
SS18-SSX2 (35%)
Translocations in undifferentiated small round cell sarcomas
CIC-DUX4
CIC-DUX4L
CIC-FOXO4
CIC-NUTM1
NUTM2A-CIC
BCOR-CCNB3
BCOR-MAML3
BCOR ITDs
Translocations in acral fibroblastic spindle cell neoplasm
EWSR1-SMAD3
Translocations in “aggressive” deep angiomyxoma
HMGA2 rearrangements
Translocations in angiofibroma of soft tissue
AHRR-NCOA2
GTF21-NCOA2
GAB1-ABL1
TBCK-PH4A2
PH4A2-TBCK
NCOA2-ETV4
ETV4-AHRR
Translocations in aneurysmal bone cyst
USP6 translocations with multiple partners
Most common is USP6-CDH11
Translocations in calcifying aponeurotic fibroma
FN1-EGF
Molecular alterations in chondroblastoma
H3F3B K36M
Translocations in chondromyxoid fibroma
COL12A1-GRM1
TBL1XR1-GRM1
BCLAF1-GRM1
Translocations in cutaneous non-neuronal granular cell tumor
SQSTM1-ALK
DCTM1-ALK
Molecular alterations in desmoid tumors
Sporadic: CTNNB1
Germline: APC
Translocations in ectomesenchymal chondromyxoid tumor
RREB1-MKL2
EWSR1 rearrangements
Translocations in epithelioid fibrous histiocytoma
ALK fusions with various partners
Translocations in fibroma of tendon sheath
USP6 translocations
Translocations in fibro-osseous pseudotumor of the digits
USP6 translocations
Molecular alterations in fibrous hamartoma of infancy
EGFR ITDs
Translocations in gastroblastoma
MALAT1-GLI1
Molecular alterations in giant cell tumor of bone
H3F3A G34W or G34V
rarely G34R or G34L
Translocations in lipoblastoma
PLAG1 rearrangements
Translocations in lipofibromatosis
HBEGF-RBM27
EGR1-GRIA1
TPR-ROS
SPARC-PDGFRB
VCL-RET
EGFR-BRAF
Translocations in lipofibromatosis-like neural tumor
NTRK1-rearrangements
Translocations in lipoma
HMGA1 or HMGA2 rearrangements
Translocations in chondroid lipoma
C11orf95-MKL2
Molecular alterations in pleomorphic/spindle cell lipoma
RB1 loss
Translocations in cellular myofibroma
SRF-RELA
Molecular alterations in myopericytoma/myofibroma
PDGFRB mutations
Translocations in myositis ossificans
USP6 rearrangements
Molecular alterations in myxomas
GNAS activating mutations
Translocations in nodular fasciitis
MYH9-USP6 (most common)
Other USP6 rearrangements
Translocations in pericytoma
ACTB-GLI1
Translocations in phosphaturic mesenchymal tumor
FN1-FGFR1
Translocations in plexiform fibromyxoma
MALAT1-GLI1
Translocations in osteoblastoma / osteoid osteoma
FOS and FOSB rearrangements
Molecular alterations in schwannoma
NF2 loss
Translocations in synovial chondromatosis
FN1-ACVR2A
or
ACVR2A-FN1
Present in both benign and malignant forms.
Translocations in tenosynovial giant cell tumor
CSF1-COL6A3
MDM2 amplified mesenchymal tumors
Defining molecular features of adipocytic neoplasms
Common molecular alterations in tumors of small vessels
Tend to have mutations in the Gaq family proteins (GNAQ, GNA11, GNA14).
Hotspot mutations in these genes disrupt GTPase activity regulating the MAPK pathway.
Molecular alterations in vascular tumors
Tumors with EWSR1 fusion to a CREB family member (CREB1, CREM, ATF1)
NCOA2
Nuclear receptor co-activator-2
Transcriptional co-activator
Interacts with ligand-bound receptors to recruit histone acetyltransferases and methyltransferases, facilitating chromatin remodeling.
Frequent 3’ fusion partner in mesenchymal neoplasms.
The C-terminal transactivation domains 1 and 2 are retained in fusion proteins.
Tumors with NCOA2 fusions
Tumors with GLI1 fusions
GLI1
GLI1 is an effector of the sonic hedgehog pathway with multiple downstream targets.
Tumors with NTRK1/2/3 fusions
SMARCB1-deficient mesenchymal neoplasms
Tumors which bare the FUS-ERG translocation
Ewing sarcoma
AML or ALL with t(16;21)
Tumors which bare the TMP3/4-ALK translocation
Inflammatory myofibroblastic tumor
Anaplastic large cell lymphoma
Renal cell carcinoma
Tumors which bare the CLTC-ALK rearrangement
Inflammatory myofibroblastic tumor
ALK positive large B cell lymphoma
Extramedullary plasmacytoma
Tumors which bare the RANBP2-ALK translocation
Inflammatory myofibroblastic tumor
ALK positive large B cell lymphoma
Myeloid leukemia
Tumors which bare the ETV6-NTRK3 fusion
Infantile fibrosarcoma
Inflammatory myofibroblastic tumor
Congenital mesoblastic nephroma, cellular type
AML/ALL
Secretory carcinoma (breast)
Mammary analogue secretory carcinoma (salivary)
Pigmented spindle cell nevus of Reed / Spitz nevus
Rare papillary thyroid carcinomas
Rare GISTs
Tumors which can bare the following translocations:
MEAF6-PHF1
EPC1-PHF1
EP400-PHF1
PHF1-TFE3
ZC3H7B-BCOR
Endometrial stromal sarcoma
Ossifying fibromyxoid tumor
Tumors which bare the ASPACR1-TFE3 translocation
Alveolar soft part sarcoma
Renal cell carcinoma
Tumors which bare the MALAT1-GLI1 translocation
Gastroblastoma
Plexiform fibromyxoma
GLI1-altered epithelioid soft tissue tumor (malignant)
Tumors which bare the TGFBR3-MGEA5
Myxoinflammatory fibroblastic sarcoma
Hemosiderotic lipomatous tumor
Pleomorphic hyalinizing angiectatic tumor
How to remember the synovial sarcoma translocation
Synovial Sarcoma on chr18 :: Synovial Sarcoma on chrX
SS18::SSX
Recurrent translocation in embryonal rhabdomyosarcoma
Just kidding! We still have no idea.
The most common mulecular feature is polysomy 8, but we still don’t really know what causes this sarcoma.